End-stage Renal Disease
End-stage renal disease is 32% more likely to develop in patients with C-reactive protein levels of 6.9 mg/L or higher vs 3.0 mg/L or lower.
Screening strategies are needed, as is further research on appropriate therapeutic approach.
More than half of newly diagnosed ESRD patients visit the emergency department during their first year of treatment.
Major fractures included the proximal humerus, forearm, hip, and clinical vertebral fractures.
Data suggest primary GN is more likely than secondary GN to result in end-stage renal disease.
No improvement in kidney failure-free days versus norepinephrine in adults with septic shock.
Highest vs lowest quartile of intake is associated with a 40% increased risk.
A higher allopurinol dose was protective against renal failure in elderly allopurinol recipients.
Researchers find an increased risk of death among patients.
High vs. low fitness levels in midlife lowered CKD risk in later life by 34%.
The risk is most elevated among individuals aged 44 years or younger.
Updated review and meta-analysis show beneficial effect for CABG for long-term mortality.
Finding suggests that olfactory deficits may contribute to nutritional impairment in patients with chronic and end-stage renal disease.
As the rate of acceleration in ESRD incidence decline, physicians should expect heightened battles for the ESRD fountains.
Nephron-sparing surgery decreased the risk of end-stage renal disease by 60% in select patients.
Findings from a small study suggest that periodontal disease may be a relevant contributing factor.
African Americans with and without a high-risk genotype experience similar kidney function decline.
In-trial reduction in risk of ESRD seen in ADVANCE trial persists after 9.9 years of follow-up.
Researchers suggest conservative care may be suitable option for some patients over 80.
The end-stage renal disease community can now capture data on depression screening and pain assessment efforts.
A new large scale study found that depending on baseline systolic blood pressure (SBP) level, the use of antihypertensive medication led to different outcomes in patients with diabetes.
Pre-dialysis CKD patients who took statins did experience a modest reduction in proteinuria and kidney function decline.
Greater visit-to-visit variability in systolic blood pressure is associated with a higher risk of ESRD or a 50% or greater decrease in eGFR.
Study finds a 3-folder greater risk of early death within a year of hemodialysis initiation.
In a phase 2 trial, roxadustat maintained hemoglobin levels over 19 weeks as well as epoetin alfa.
Four patients would need to adhere to diet to avoid primary end point in per-protocol analysis.
Factors include care practices of physicians, sources of momentum, patient-physician interactions.
New risk calculator estimates who will need dialysis in 2 to 5 years.
Severe hypoglycemia may result in changes in mental state, seizures, arrhythmias, coma, and death.
Screening not linked to improved patient survival after transplant; may delay time to listing, transplant.
Renal and Urology News Articles
- Uric Acid Threshold That Predicts Kidney Stone Formation Identified
- Hypogonadism in Male HD Patients Linked to Poor ESA Response
- Bladder Cancer Progression Linked to Collagen Changes
- Elevated CRP Linked With CKD Risk in Rheumatoid Arthritis
- Losartan Reduces Aldosterone in Hypertension Without Sleep Apnea
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)